RT Journal Article
SR Electronic
T1 Multinational attitudes towards AI in healthcare and diagnostics among hospital patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.01.24312016
DO 10.1101/2024.09.01.24312016
A1 Busch, Felix
A1 Hoffmann, Lena
A1 Xu, Lina
A1 Zhang, Longjiang
A1 Hu, Bin
A1 García-Juárez, Ignacio
A1 Toapanta-Yanchapaxi, Liz N
A1 Gorelik, Natalia
A1 Gorelik, Valérie
A1 Rodriguez-Granillo, Gaston A
A1 Ferrarotti, Carlos
A1 Cuong, Nguyen N
A1 Thi, Chau AP
A1 Tuncel, Murat
A1 Kaya, Gürsan
A1 Solis-Barquero, Sergio M
A1 Mendez Avila, Maria C
A1 Ivanova, Nevena G
A1 Kitamura, Felipe C
A1 Hayama, Karina YI
A1 Puntunet Bates, Monserrat L
A1 Torres, Pedro Iturralde
A1 Ortiz-Prado, Esteban
A1 Izquierdo-Condoy, Juan S
A1 Schwarz, Gilbert M
A1 Hofstaetter, Jochen G
A1 Hide, Michihiro
A1 Takeda, Konagi
A1 Perić, Barbara
A1 Pilko, Gašper
A1 Thulesius, Hans O
A1 Lindow, Thomas A
A1 Kolawole, Israel K
A1 Olatoke, Samuel Adegboyega
A1 Grzybowski, Andrzej
A1 Corlateanu, Alexandru
A1 Iaconi, Oana-Simina
A1 Li, Ting
A1 Domitrz, Izabela
A1 Kępczyńska, Katarzyna
A1 Mihalčin, Matúš
A1 Fašaneková, Lenka
A1 Zatoński, Tomasz
A1 Fułek, Katarzyna
A1 Molnár, András
A1 Maihoub, Stefani
A1 Gama, Zenewton A da Silva
A1 Saba, Luca
A1 Sountoulides, Petros
A1 Makowski, Marcus R
A1 Aerts, Hugo JWL
A1 Adams, Lisa C
A1 Bressem, Keno K
A1 ,
YR 2024
UL http://medrxiv.org/content/early/2024/09/02/2024.09.01.24312016.abstract
AB The successful implementation of artificial intelligence (AI) in healthcare is dependent upon the acceptance of this technology by key stakeholders, particularly patients, who are the primary beneficiaries of AI-driven outcomes. This international, multicenter, cross-sectional study assessed the attitudes of hospital patients towards AI in healthcare across 43 countries. A total of 13806 patients at 74 hospitals were surveyed between February and November 2023, with 64.8% from the Global North and 35.2% from the Global South. The findings indicate a predominantly favorable general view of AI in healthcare, with 57.6% of respondents expressing a positive attitude. However, attitudes exhibited notable variation based on demographic characteristics, health status, and technological literacy. Female respondents and those with poorer health status exhibited fewer positive attitudes towards AI use in medicine. Conversely, higher levels of AI knowledge and frequent use of technology devices were associated with more positive attitudes. It is noteworthy that less than half of the participants expressed positive attitudes regarding all items pertaining to trust in AI. The lowest level of trust was observed for the accuracy of AI in providing information regarding treatment responses. Patients exhibited a strong preference for explainable AI and physician-led decision-making, even if it meant slightly compromised accuracy. This large-scale, multinational study provides a comprehensive perspective on patient attitudes towards AI in healthcare across six continents. Findings suggest a need for tailored AI implementation strategies that consider patient demographics, health status, and preferences for explainable AI and physician oversight. All study data has been made publicly available to encourage replication and further investigation.Competing Interest StatementThe authors declare the following competing interests: Petros Sountoulides, Keno K Bressem, Renato Cuocolo, Virginia Dignum, Guillermo de Velasco, Alessa Hering, Lili Jiang, George Kolostoumpis, and Alexander Loeser report research grants from the European Commission (101079894); Keno K Bressem reports grants from the Wilhelm Sander Foundation and speaker fees from Canon Medical Systems Corporation and GE Healthcare, and is a member of the advisory board of the EU Horizon 2020 LifeChamps project (875329) and the EU IHI project IMAGIO (101112053); Martina Aineseder reports consultant fees from Segmed, Inc.; Giovanna Ferraioli reports speaker honoraria from Canon Medical Systems, Fujifilm Healthcare, Mindray Healthcare, Philips Healthcare, and Siemens Healthineers, is an advisory board member for Philips Healthcare and Siemens Healthineers and receives royalties from Elsevier; Giovanna Ferraioli's university received equipment grants and unrestricted research grants from Canon Medical Systems, Philips Ultrasound, and Siemens Healthineers. None of the other authors declares potential conflicts of interest.Funding StatementThis research is funded by the European Union (COMFORT (Computational Models FOR patienT stratification in urologic cancers - Creating robust and trustworthy multimodal AI for health care), project number: 101079894, authors involved: Petros Sountoulides, Renato Cuocolo, Virginia Dignum, Guillermo de Velasco, Alessa Hering, Lili Jiang, George Kolostoumpis, Alexander Loeser, principal investigator: Keno K Bressem, sponsors' website: https://www.comfort-ai.eu). Views and opinions expressed are, however, those of the authors only and do not necessarily reflect those of the European Union. The European Union cannot be held responsible for them. The funding had no role in the study design, data collection and analysis, manuscript preparation, or decision to publish.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained from the Charité - Universitätsmedizin Berlin (EA4/213/22), which served as the lead institution, and from all other participating hospitals according to their institutional policies (see eTable 14). Given the unsupervised and anonymous design of the instrument, informed consent was waived to preserve participant anonymity.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe full dataset and data dictionary are publicly available under CC-BY 4.0 international license at figshare. https://doi.org/10.6084/m9.figshare.24964488